News & Events

  • March 07, 2012

    Barry I. Grossman, a member of the Firm was invited by Capital Link to participate in their 3rd Annual Greek Shipping Forum in Athens, Greece.  Mr. Grossman spoke on Alternative Public Offerings and what Companies Need to Know.

    Click here to view the Presentation

  • March 06, 2012

    The Supreme Court, State of New York, entered a permanent injunction staying a FINRA arbitration brought by an individual against a Broker-Dealer. The individual alleged that the Broker-Dealer's former employee had sold him shares in a private placement. On the motion, EG&S successfully showed that the individual had never been a customer of the firm and that it was not likely that he could show that he was even a "customer" of the employee or had a sound basis to believe he was. Partner Adrienne Ward led the effort, with assistance from associate Holly Froum.

     

  • February 22, 2012

    People’s Liberation, Inc. announced the closing of their Private Placement in the amount of $11,500,000. EG&S acted as counsel to the Investor.

  • February 20, 2012

    Superconductor Technologies Inc. announced the closing of their Registered Direct offering in the amount of $4,563,535. EG&S acted as counsel to the placement agent.
     

  • February 15, 2012

    Cardium Therapeutics, Inc. announced the closing of their Registered Direct in the amount of $5,000,000. EG&S acted as counsel to the placement agent.
     

  • February 14, 2012

    Apps Genius Corp announced the closing of their Registered Direct offering in the amount of $1,000,000.  EG&S acted as counsel to the placement agent.

  • February 10, 2012

    Neuralstem, Inc. announced the closing of their Registered Direct offering in the amount of $5,050,000.  EG&S acted as counsel to the placement agent.
     

  • February 10, 2012

    EpiCept Corporation announced the closing of their Registered Direct offering in the amount of $2,000,000. EG&S acted as counsel to the placement agent.
     

  • February 09, 2012

    Advaxis, Inc. announced the closing of their PIPE offering in the amount of $1,047,500. EG&S acted as counsel to the placement agent.
     

  • February 07, 2012

    Spherix Incorporated announced the closing of their Registered Direct offering in the amount of $1,150,001. EG&S acted as counsel to the placement agent.
     

  • February 06, 2012

    Jones Soda Co. announced the closing of their Registered Direct offering in the amount of $3,207,500. EG&S acted as counsel to the placement agent.
     

  • February 03, 2012

    Generex Biotechnology Corporation announced the closing of their PIPE offering in the amount of $2,000,000. EG&S acted as counsel to Generex.
     

  • February 02, 2012

    Hyperdynamics Corporation announced the closing of their Registered Direct offering in the amount of $30,000,000. EG&S acted as counsel to the placement agent.
     

  • January 30, 2012

    Cel-Sci Corporation announced the closing of their Registered Direct offering in the amount of $5,760,000.  EG&S acted as counsel to the placement agent.
     

  • January 20, 2012

    DARA BioSciences, Inc. announced the closing of their Registered Direct offering in the amount of $1,700,000. EG&S acted as counsel to the placement agent.
     

  • January 18, 2012

    NutraCea announced the closing of their PIPE offering in the amount of $870,000. EG&S acted as counsel to NutraCea.
     

  • January 17, 2012

    Barry Grossman gave a presentation on the requirements and methodologies used to Go Private and participated on a panel discussing Privatization of Chinese Companies.

    Click here to view the presentation

  • January 11, 2012

    Ellenoff Grossman & Schole LLP was ranked #4 for issuer representation in IPO transactions  (by number of transactions) for 2011.

    Click here to view the rankings

  • January 04, 2012

    Ellenoff Grossman & Schole LLP was ranked #1 for placement agent representation in PIPE transactions (by number of transactions) for 2011.

    Click here to view the rankings

  • December 30, 2011

    AspenBio Pharma, Inc. announced the closing of their registered direct offering in the amount of $1,637,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Oculus Innovative Sciences, Inc. announced the closing of their registered direct offering in the amount of $2,081,100.  EG&S acted as counsel to the Placement Agent.
     

  • December 28, 2011

    Quadrant 4 Systems Corporation announced the closing of their private placement in the amount of $800,000.  EG&S acted as counsel to the Investor.
     

  • December 27, 2011

    Catasys, Inc. announced the closing of their registered direct offering in the amount of $974,999. EG&S acted as counsel to the Placement Agent.
     

  • December 21, 2011

    StemCells, Inc. announced the closing of their underwritten public offering in the amount of $10,000,000. EG&S acted as counsel to the Underwriter.
     

  • December 13, 2011

    PhotoMedex, Inc., a NASDAQ listed company, and Radiancy, Inc., a private Delaware company,  announced the completion of their merger.  Pursuant to the merger, the former stockholders of Radiancy received shares of Photomedex valued on the date of closing at approximately $235 million and collectively own approximately 75% of PhotoMedex, Inc. following the merger. Radiancy became a majority-owned subsidiary of PhotoMedex. EG&S acted as counsel to Radiancy.